COMMUNIQUÉS West-GlobeNewswire

Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
26/03/2019
Menarini Diagnostics to distribute Unyvero Platform and application cartridges in numerous European countries Menarini Diagnostics to deploy its commercial team for the marketing of Unyvero Platform across Europe [...]
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
26/03/2019
LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
26/03/2019
Moving forward with Overall Survival (OS)-based, randomized, event-driven clinical trial for the United States Pre-IND feedback from US Food and Drug Administration (FDA) provides clarity to Nanobiotix on US regulatory [...]
Nanobiotix annonce son plan d’enregistrement clinique dans les cancers de la Tête et du Cou avec NBTXR3 aux Etats-Unis à la suite du retour de la FDA
26/03/2019
Préparation d’une étude clinique évènementielle, randomisée et évaluant la survie globale (SG) aux États-Unis Le retour (pre-IND) de la Food and Drug Administration (FDA) permet de clarifier l’approche réglementaire aux [...]
Tecan publishes 2018 Annual Report and notice of its Annual General Meeting
26/03/2019
Männedorf, Switzerland, March 26, 2019 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2018 Annual Report in the Investor Relations section of the company's website at www.tecan.com [...]
Multidisciplinary Experts Leverage Global Action for Local Impact to Protect Communities at Risk of Typhoid and Related Diseases
26/03/2019
HANOI, Vietnam, March 25, 2019 (GLOBE NEWSWIRE) -- Beginning today, the 11 th International Conference on Typhoid and Other Invasive Salmonelloses brings together more than 450 researchers, policy makers and advocates [...]
Novel compound for treatment of traumatic brain injury (TBI) demonstrates positive results in a preclinical study
25/03/2019
Strongest announced preclinical results of any drug candidate currently in development for TBI Significant results in neurobehavior as measured by actigraphy. GRAFTON, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Ischemix [...]
RadNet, Inc. to Present at the Sidoti & Company Spring 2019 Conference on Thursday, March 28th
25/03/2019
LOS ANGELES, March 25, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Precision Therapeutics Announces Results of Special Meeting of Stockholders
25/03/2019
MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (the “Company”) announced today that at a special meeting of stockholders held on March 22, 2019, the Company’s stockholders [...]
Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019
25/03/2019
Conference Call to be held April 1, 2019, at 4:30pm Eastern Time MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces that it will [...]
Agritek Holdings Inc. Announces Reverse Stock Split in Preparation for Proposed Uplisting To National Markets And OTCQB
25/03/2019
LOS ANGELES, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for [...]
PhaseBio Announces Term Loan of up to $15 Million
25/03/2019
Entered into term loan facility with Silicon Valley Bank and WestRiver Innovation Lending Fund to borrow up to $15 million Funds will be used to advance clinical development of PB2452, a reversal agent for ticagrelor, [...]
Kane Biotech Announces Fourth Quarter and Full Year 2018 Financial Results
25/03/2019
WINNIPEG, Manitoba, March 25, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
CytomX Therapeutics Announces Transition of Chief Financial Officer
25/03/2019
SOUTH SAN FRANCISCO, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
BriaCell Closes First Tranche of Previously Announced Non-Brokered Private Placement
25/03/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, March 25, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
MRI Interventions Congratulates Dr. Clark Chen On First Patient Dosing In Minnesota For Phase 2 Glioblastoma Trial
25/03/2019
IRVINE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration [...]
Yield10 Bioscience Announces Fourth Quarter and Full Year 2018 Financial Results
25/03/2019
WOBURN, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
MyoKardia Announces Proposed Public Offering of Common Stock
25/03/2019
SOUTH SAN FRANCISCO, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious [...]
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares
25/03/2019
ANN ARBOR, Mich., March 25, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced it [...]

Pages